HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Werngard Czechtizky Selected Research

tetrahydro-pyran-4-carboxylic acid (2- methyl- 4- (2- methyl- (1,3')bipyrrolidinyl- 1'- yl)phenyl)amide

11/2013Discovery of a potent, selective, and orally bioavailable histamine H3 receptor antagonist SAR110068 for the treatment of sleep-wake disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Werngard Czechtizky Research Topics

Disease

3Obesity
07/2014 - 06/2013
2Chronic Obstructive Pulmonary Disease (COPD)
09/2023 - 03/2022
1Idiopathic Pulmonary Fibrosis
09/2023
1Lung Diseases (Lung Disease)
02/2023
1Asthma (Bronchial Asthma)
03/2022
1Insulin Resistance
07/2014
1Sleep Wake Disorders
11/2013
1Neoplasms (Cancer)
10/2013

Drug/Important Bio-Agent (IBA)

2Peptides (Polypeptides)IBA
02/2023 - 03/2022
2Histamine H3 AntagonistsIBA
06/2013 - 06/2013
2AmidesIBA
06/2013 - 06/2013
1MicroRNAs (MicroRNA)IBA
09/2023
1Peptide Hydrolases (Proteases)FDA Link
03/2022
1SAR088IBA
07/2014
1phosphatidylinositol 5-phosphateIBA
07/2014
1Histamine H3 Receptors (Histamine H3 Receptor)IBA
11/2013
1tetrahydro-pyran-4-carboxylic acid (2- methyl- 4- (2- methyl- (1,3')bipyrrolidinyl- 1'- yl)phenyl)amideIBA
11/2013
1Phosphotransferases (Kinase)IBA
10/2013